Publication: Nonalcoholic fatty liver disease and albuminuria: A systematic review and meta-analysis
Issued Date
2018-09-01
Resource Type
ISSN
14735687
0954691X
0954691X
Other identifier(s)
2-s2.0-85051103414
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
European Journal of Gastroenterology and Hepatology. Vol.30, No.9 (2018), 986-994
Suggested Citation
Karn Wijarnpreecha, Charat Thongprayoon, Boonphiphop Boonpheng, Panadeekarn Panjawatanan, Konika Sharma, Patompong Ungprasert, Surakit Pungpapong, Wisit Cheungpasitporn Nonalcoholic fatty liver disease and albuminuria: A systematic review and meta-analysis. European Journal of Gastroenterology and Hepatology. Vol.30, No.9 (2018), 986-994. doi:10.1097/MEG.0000000000001169 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/46412
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Nonalcoholic fatty liver disease and albuminuria: A systematic review and meta-analysis
Abstract
© 2018 Wolters Kluwer Health, Inc. All rights reserved. Background/objectives The relationship between nonalcoholic fatty liver disease (NAFLD) and albuminuria has been shown in many epidemiologic studies, although the results were inconsistent. This meta-analysis was conducted to summarize all available data and to estimate the risk of albuminuria among patients with NAFLD. Methods Comprehensive literature review was conducted utilizing Medline and Embase database through January 2018 to identify studies that compared the risk of albuminuria among patients with NAFLD versus those without NAFLD. Effect estimates from each study were extracted and combined using the random-effect, generic inverse variance method of DerSimonian and Laird. Results Nineteen studies (17 cross-sectional studies and two cohort studies) with 24 804 participants fulfilled the eligibility criteria and were included in this meta-analysis. The risk of albuminuria among patients with NAFLD was significantly higher than those without NAFLD with the pooled odds ratio (OR) of 1.67 [95% confidence interval (CI): 1.32-2.11]. Subgroup analysis demonstrated the significantly increased risk of albuminuria among patients with NAFLD without diabetes with pooled OR of 2.25 (95% CI: 1.65-3.06). However, we found no significant association between albuminuria and NAFLD among diabetic patients [pooled OR 1.28 (95% CI: 0.94-1.75)]. Conclusion A significantly increased risk of albuminuria among patients with NAFLD was observed in this meta-analysis. Physicians should pay more attention to the early detection and subsequent treatment of individuals with microalbuminuria especially in patients with NAFLD.